Tags : Pregnancy

Regulatory

Biogen’s Plegridy (peginterferon beta-1a) and Avonex (interferon beta-1a) Receive CHMP’s

Shots: The CHMP recommended an update to MAA of approved interferon beta treatments (Plegridy & Avonex) to remove pregnancy contraindications and allow them to use during pregnancy and breastfeeding in women with relapsing multiple sclerosis The CHMP positive opinion is based on 1,000+ real-world pregnancy outcomes demonstrating no increased risk of major congenital anomalies after […]Read More

M&A

Everyday Health Group to Acquire Johnson and Johnson’s BabyCenter a

Shots: Everyday Health acquires BabyCenter combining its What to Expect digital pregnancy and parenting platform, with the focus of supporting parents through the journey of pregnancy and early parenting plus combined expertise for engaging digital experiences of parenthood What to Expect is Everyday Health’s first rated digital pregnancy app in the Apple Store, awarded under […]Read More

Regulatory

Therapeutics MD’s Annovera (Segesterone Acetate/Ethinyl Estradiol) Receives FDA Approval for

Shots: The approval is based on 17 clinical trials results assessing Annovera in 2,308 women aged ≤35yrs The study demonstrated in prevention of 97.3% pregnancy, Pearl Index (PI) 2.98/100 women with overall satisfaction rate is 89% Annovera is a combination of estrogen (ethinyl estradiol, 0.15 mg/day) & Nestorone (segesterone acetate,0.013 mg/day) used for prevention of ovulation […]Read More